Message
Preface
Fujita Health University was established in 1971. Next years, Institute for Comprehensive Medical Science(ICMS) consisting of research divisions in the form of project-teams which will develop into a spearhead of modern medical research was also established. According to the late President Keisuke Fujita, Comprehensive Medicine should be considered as the medical science which tries to comprehend and understand the illness of a patient as the whole man. Based on the realization of strong impact of molecular biology on medical field, Dr. KeisukeFujita newly built the No.3 Building of the School of Medicine and set up four divisions of Molecular Genetics, Biomedical Polymer Sciences, Cell Biology and Immunology. Each research division was expected to contribute to progress in medicine and medical science; the development of drugs and hormones for treating senile dementia, alcoholism and depression, inhibiting carcinogenesis, and suppressing aging and the development of strong analgetics free of side-effects, vaccines against tuberculosis, vaccines and immunological therapy against particular types of cancer, methods for gene diagnosis and gene therapy against many hereditary illness, methods for prevention and treatment against many other incurable diseases, some types of artificial organs and artificial blood, and so on.
While 36 years have passed after establishment of ICMS (field of molecular medicine), now it consists of six research divisions, Molecular Genetics, Biomedical Polymer Science, Therapies against Intractable Diseases, Gene Expression Mechanism, Systems Medical science, and Antibody Project. One division is composed of five tenure research positions including one professor and thirty scientists can devote themselves only to research without duty of education to undergraduate students. Thus, the goals that the late Dr. KeisukeFujita raised one quarter of century ago must not remain as a dream but be understood as a public health. We have been trying to achieve these purposes.
April, 2011
Director Keiichiro Hashimoto
While 36 years have passed after establishment of ICMS (field of molecular medicine), now it consists of six research divisions, Molecular Genetics, Biomedical Polymer Science, Therapies against Intractable Diseases, Gene Expression Mechanism, Systems Medical science, and Antibody Project. One division is composed of five tenure research positions including one professor and thirty scientists can devote themselves only to research without duty of education to undergraduate students. Thus, the goals that the late Dr. KeisukeFujita raised one quarter of century ago must not remain as a dream but be understood as a public health. We have been trying to achieve these purposes.
April, 2011
Director Keiichiro Hashimoto